IP Library Granted Patent US 7,725,168
Granted Patent B2
US 7,725,168 · App. 11/551,792 · Granted May 25, 2010

Powerhead of a power injection system

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,725,168
App. No.
11/551,792
Granted
May 25, 2010
Kind
B2
Abstract

A contrast media injection system includes detects the absolute position of the syringe ram using a non-contact sensor. A series of magnets and Hall-Effect sensors may be used or an opto-reflective system. Illuminated knobs that are connected to the drive mechanism for the syringe ram rotate with the drive and provide visual feedback on operation through the illumination. Analog Hall-Effect sensors are used to determine the presence or absence of magnets that identify the type of faceplate being used. The faceplates include control electronics, connected to the powerhead through connectors, which may be interchangeably used by the two faceplates. The faceplate electronics include detectors for automatically detecting the capacity of pre-filled syringes. Additional features include using historical data to provide optimum pressure limit values during an injection protocol, a removable memory device for storing and transferring information such as injection protocols and injector statistics, and password protection of such protocols.

Claims (34)

1. A contrast media injector system comprising:

a powerhead including a syringe ram and a drive mechanism coupled with the syringe ram;

a faceplate removably mounted to the powerhead, wherein the faceplate has an open condition and a closed condition; and

circuitry configured to control the drive mechanism to move the syringe ram relative to the faceplate to effect an injection of a contrast media into a patient, the circuitry including programming for moving the syringe ram to a first position that prevents removal of the faceplate from the powerhead, wherein the programming of the circuitry is further configured to permit selective movement of the syringe ram to a second position that permits removal of the faceplate from and attachment of the faceplate to the powerhead, wherein the programming is further configured to prevent movement of the syringe ram from the first position to the second position while the faceplate is in the closed condition, and wherein the programming is further configured to allow movement of the syringe ram from the first position to the second position while the faceplate is in the open condition.

2. The contrast media injector system of claim 1 , further comprising a syringe removably coupled to the powerhead via the faceplate.

3. The contrast media injector system of claim 1 wherein disposing the faceplate in the open condition allows an associated syringe to be removed from the powerhead, and wherein disposing the faceplate in the closed condition couples a corresponding syringe to the syringe ram.

4. The contrast media injector system of claim 1 wherein the programming of the control circuit is further configured to permit movement of the syringe ram from the first position to the second position while the faceplate is in the open condition.

5. The contrast media injector system of claim 1 wherein the programming of the circuitry is configured to permit the syringe ram to move from the second position to the first position when the faceplate is initially mounted to the powerhead.

6. The contrast media injector system of claim 1 wherein the powerhead includes a mating surface and a plurality of channels on the mating surface, and the faceplate includes a mating surface and a plurality of channels on the mating surface that are configured to be engaged with the channels on the mating surface of the powerhead.

7. The contrast media injector system of claim 1 , further comprising a syringe removably coupled to the powerhead, wherein disposing the faceplate in the open condition allows the syringe to be installed on the powerhead via the faceplate, and wherein disposing the faceplate in the closed condition couples the syringe to the syringe ram.

8. The contrast media injector system of claim 1 wherein the faceplate has an aperture positioned to receive a portion of the syringe ram when the syringe ram is in the first position.

9. A method of operating a contrast media injector system that includes a powerhead with a syringe ram and a faceplate having an open condition and a closed condition, where the faceplate is configured to removably mount a syringe to the powerhead, the method comprising:

selectively moving the syringe ram of the powerhead relative to the faceplate from a second position into a first position, wherein the second position permits removal of the faceplate from and attachment of the faceplate to the powerhead and the first position prevents removal of the faceplate from the powerhead;

moving the faceplate from the closed condition to the open condition and while the syringe ram is in the first position;

selectively moving the syringe ram of the powerhead relative to the faceplate from the first position to the second position, after the moving the faceplate, and while the faceplate is maintained in the open condition; and

prohibiting movement of the syringe ram from the first position to the second position while the faceplate is in the closed condition.

10. The method of claim 9 further comprising:

removing the faceplate from the powerhead after the syringe ram is moved from the first position to the second position.

11. The method of claim 10 wherein the selectively moving the syringe ram from the first position to the second position further comprises:

permitting movement of the syringe ram from the first position to the second position only while the faceplate is in the open condition.

12. The method of claim 9 further comprising:

associating a syringe with the faceplate, where the syringe includes a syringe plunger; and

coupling the syringe plunger with the syringe ram by changing the faceplate from the open condition to the closed condition.

13. The method of claim 9 wherein the selectively moving the syringe ram of the powerhead relative to the faceplate from the second position to the first position further comprises:

advancing the syringe ram into an aperture in the faceplate to establish the first position.

14. The method of claim 9 wherein:

the selectively moving of the syringe ram from the first position to the second position comprises moving the syringe ram from the first position to the second positions, wherein the moving the syringe ram is executed after the moving the faceplate and while the faceplate is maintained in the open condition, and wherein the method further comprises:

removing the faceplate after the moving the syringe ram;

mounting a new faceplate to the powerhead while the syringe ram is in the second position and after the removing the faceplate; and

selectively moving the syringe ram of the powerhead relative to the new faceplate into the first position to prevent removal of the new faceplate from the powerhead.

15. A contrast media injector system comprising:

a powerhead including a syringe ram and a drive mechanism coupled with the syringe ram;

a faceplate removably mounted to the powerhead, wherein the faceplate has an open condition and a closed condition, wherein disposing the faceplate in the open condition allows an associated syringe to be removed from the powerhead, and wherein disposing the faceplate in the closed condition couples a corresponding syringe to the syringe ram; and

circuitry configured to control the drive mechanism to move the syringe ram relative to the faceplate to effect an injection of a contrast media into a patient, including moving the syringe ram to a first position that prevents removal of the faceplate from the powerhead, and wherein the circuitry is further configured to permit selective movement of the syringe ram to a second position that permits removal of the faceplate from and attachment of the faceplate to the powerhead, and wherein when the syringe ram is in the first position, the faceplate is moveable between the open condition and the closed condition.

Assignments (6)
RELEASE OF PATENT SECURITY INTERESTS RECORDED AT REEL 032480, FRAME 0001 Recorded Nov 16, 2023
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: THERAKOS, INC.; MALLINCKRODT INTERNATIONAL FINANCE S.A.; MALLINCKRODT CB LLC; MALLINCKRODT FINANCE GMBH; MALLINCKRODT US HOLDINGS LLC (F/K/A MALLINCKRODT US HOLDINGS INC.); MALLINCKRODT CARRIBEAN, INC.; MALLINCKRODT US POOL LLC; MNK 2011 LLC (F/K/A MALLINCKRODT INC.); LUDLOW LLC (F/K/A LUDLOW CORPORATION); CNS THERAPEUTICS, INC.; MALLINCKRODT ENTERPRISES HOLDINGS LLC (F/K/A MALLINCKRODT ENTERPRISES HOLDINGS, INC.); MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; LAFAYETTE PHARMACEUTICALS LLC; LIEBEL-FLARSHEIM COMPANY LLC; MALLINCKRODT BRAND PHARMACEUTICALS LLC (F/K/A MALLINCKRODT BRAND PHARMACEUTICALS, INC.); MALLINCKRODT VETERINARY, INC.; MALLINCKRODT US HOLDINGS LLC; IMC EXPLORATION COMPANY; MEH, INC.; MALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY (F/K/A MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED); MALLINCKRODT ARD IP UNLIMITED COMPANY (F/K/A MALLINCKRODT ARD IP LIMITED); OCERA THERAPEUTICS LLC (F/K/A OCERA THERAPEUTICS, INC.); SPECGX LLC; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC (F/K/A VTESSE INC.); MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY (F/K/A MALLINCKRODT PHARMA IP TRADING D.A.C.); INFACARE PHARMACEUTICAL CORPORATION; ST SHARED SERVICES LLC; IKARIA THERAPEUTICS LLC; INO THERAPEUTICS LLC
Reel/Frame 065609/0322 →
RELEASE OF SECURITY INTEREST Recorded Nov 30, 2015
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: LIEBEL-FLARSHEIM COMPANY LLC
Reel/Frame 037172/0094 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 31, 2014
From: MALLINCKRODT LLC
To: LIEBEL-FLARSHEIM COMPANY LLC
Reel/Frame 034715/0531 →
SECURITY INTEREST Recorded Mar 19, 2014
From: MALLINCKRODT INTERNATIONAL FINANCE S.A.; MALLINCKRODT CB LLC; MALLINCKRODT FINANCE GMBH; MALLINCKRODT US HOLDINGS INC.; MALLINCKRODT CARIBBEAN, INC.; MALLINCKRODT US POOL LLC; MALLINCKRODT INC.; LUDLOW CORPORATION; CNS THERAPEUTICS, INC.; ENTERPRISES HOLDINGS, INC.; MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; LAFAYETTE PHARMACEUTICALS LLC; LIEBEL-FLARSHEIM COMPANY LLC; MALLINCKRODT BRAND PHARMACEUTICALS, INC; MALLINCKRODT VETERINARY, INC.; MALLINCKRODT US HOLDINGS LLC; IMC EXPLORATION COMPANY; MEH, INC; MALLINCKRODT ENTERPRISES HOLDINGS, INC.
To: DEUTSCHE BANK AG NEW YORK BRANCH
Reel/Frame 032480/0001 →
CHANGE OF LEGAL ENTITY Recorded Aug 16, 2011
From: MALLINCKRODT INC.
To: MALLINCKRODT LLC
Reel/Frame 026754/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 30, 2007
From: NEER, CHARLES S.; GIBBS, JONATHAN D.; BRUCE, JOHN KEVIN; ZIEMBA, ROBERT J.; BROOKS, DAVID M.; SMALL, JAMES R.; WAGNER, GARY S.
To: MALLINCKRODT INC.
Reel/Frame 019355/0588 →